AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bretolap Tablet

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Lapatinib (250mg)

Overview Bretolap Tablet

Oncaspar tablets are indicated for the management of breast cancer. Their mechanism involves inhibiting or retarding cancerous cell proliferation. This medication may be administered alone or in conjunction with other therapies to address advanced-stage breast cancers. Optimal absorption is achieved by ingesting Oncaspar on an empty stomach, or at least one hour prior to, or two hours after, meals. Dosage and treatment length are individualized based on disease severity and patient response. Strict adherence to the prescribed regimen is crucial to minimize adverse effects. Therapeutic benefits may not be immediately apparent, often requiring weeks or months to manifest; discontinuation should only occur under medical supervision. Commonly reported side effects encompass nausea, cephalgia, back discomfort, and respiratory distress. Severe diarrhea warrants increased fluid intake or immediate medical attention. Regular blood pressure monitoring is typically recommended. Report any severe headache, disorientation, visual disturbances, persistent nausea, or emesis to your physician. Liver function assessment is usually performed before, during, and following treatment. Prior to commencing Oncaspar, disclose any pre-existing hepatic or renal impairment. Drug interactions are possible; therefore, complete disclosure of all medications to your healthcare provider is essential. This medication is contraindicated during gestation and lactation. Reliable contraception for both partners is paramount throughout treatment to prevent conception.

Primary Ingredients of Bretolap Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Bretolap Tablet

Malignant mammary tumor

Major Benefits of Bretolap Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Bretolap Tablet on an empty stomach.

Common Side effects of Bretolap Tablet:

  • Abdominal pain
  • Back pain
  • Breathing problems
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Headache
  • Hot flashes
  • Increased bilirubin in the blood
  • Insomnia (difficulty in sleeping)
  • Joint pain
  • Liver damage
  • Loss of appetite
  • Mucosal inflammation
  • Nausea
  • Pain in extremities
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight gain

How to use Bretolap Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Bretolap Tablet on an empty stomach.

How Bretolap Tablet works:

Bretolap tablets are an anticancer drug targeting HER2 and EGFR receptors. By blocking these receptors, responsible for excessive cell growth, Bretolap disrupts the cellular signaling pathways that fuel cancer proliferation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Bretolap Tablet hasn't been established as safe. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Bretolap Tablet is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Use of Bretolap Tablet is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Bretolap Tablet.

KidneyKidneyCAUTION

Exercise caution when administering Bretolap Tablet to individuals with severe kidney impairment; dosage modification may be necessary. Seek medical advice. Data regarding Bretolap Tablet use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney disease.

LiverLiverCAUTION

Patients with hepatic impairment should use Bretolap Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Data regarding its use in individuals with severe liver disease is scarce.

What if you forget to take Bretolap Tablet :

Omit a Bretolap Tablet dose? Seek your physician's advice.

Facts to Know About Bretolap Tablet

LabelValue
Chemical Classification Quinazoline Amine Derivative
Developing Habits No.
Type of Therapy Cancer Medications
Action Class Kinase inhibitors targeting tyrosine

FAQs on Bretolap Tablet

This targeted anti-cancer drug, Bretolap Tablet, is a tyrosine kinase inhibitor. Unlike chemotherapy, it acts specifically by blocking the abnormal protein responsible for cancer cell growth, thus hindering or slowing cancer's spread.
Bretolap Tablet is used in combination with other anti-cancer medications. Specifically, it's combined with capecitabine for advanced breast cancer patients previously treated with chemotherapy, and with letrozole for postmenopausal women with breast cancer.
Always follow your doctor's instructions when taking Bretolap Tablets. Take each tablet whole with water, at the same time daily, either one hour before or one hour after a meal, maintaining consistency with your meal timing.
Bretolap Tablet can cause liver damage, ranging from serious to life-threatening, potentially developing within days or months of starting treatment. Disclose any history of liver disease to your doctor. Seek immediate medical attention if you experience symptoms like itching, yellowing skin or eyes, discolored urine, upper right abdominal pain, unusual bleeding or bruising, or pale or dark stools.
Experience diarrhea while taking Bretolap Tablets? Increase your fluid intake (8-10 glasses daily) with water, sports drinks, or clear liquids. Opt for low-fat, high-protein foods over fatty or spicy options. Cooked vegetables and peeled fruits are preferable. Avoid milk products and herbal supplements, as some can worsen diarrhea. If diarrhea continues, contact your doctor; treatment may be adjusted.
Your doctor will monitor your skin throughout your treatment. For sensitive skin, use fragrance-free, hypoallergenic cleansers and cosmetics. Daily sunscreen with SPF 30 or higher is recommended. Report any rashes to your doctor immediately.
To ensure your heart and liver function properly while taking Bretolap Tablet, additional tests may be necessary. Bretolap Tablet can alter your heartbeat and blood circulation, so your doctor will closely monitor its effects on your heart and liver. Treatment adjustments, including dose changes or discontinuation, will depend on the test results.
Prevent pregnancy by using reliable contraception throughout your Bretolap Tablet treatment and for at least one week afterward. Notify your doctor immediately if you become pregnant; they will determine the appropriate course of action.
Bretolap Tablet
5,175
MRP 5,990
13% off